CTOs on the Move


 
Dentive is a dental service organization that provides business consulting and services to dentists.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Dove Tree Medical Staffing

Dove Tree Medical Staffing is a Columbia, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Electra-Med Corp

Electra-Med Corp is a Flint, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aratana Terapeutics

Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.

Animal Internal Medicine & Specialty Services - AIMSS

Animal Internal Medicine and Specialty Services (AIMSS) partners with Animal Emergency Services to provide the best specialty, emergency and critical pet care in the San Francisco Bay Area. We are locally owned and operated. Our team of board-certi...

Clarvista Medical

ClarVista Medical` based in Aliso Viejo` California is a leading developer of innovative products to treat challenging ophthalmic conditions. In 2012 and in conjunction with series A financing` ClarVista was spun out from Prospex Medical` a medical device incubator` to pursue the development of the HARMONI™ IOL. Between 2012 and 2014` the company developed the first generation HARMONI™ system` conducted thorough first-in-human clinical study and developed a broad portfolio of intellectual property. In 2015 the company closed on a series B financing of $14M which will be used to develop the second generation HAROMONI™ system` conduct a larger feasibility clinical trial and obtain key regulatory approvals including CE mark and US IDE.